![[국제]China is also the first to approve the vaccine for its own country’s Sinofam…prevention rate is 79.3%](https://image.ytn.co.kr/general/jpg/2020/1231/202012311808211477_t.jpg "[국제]China is also the first to approve the vaccine for its own country’s Sinofam…prevention rate is 79.3%")
China’s Sinopharm postpones the release of detailed data… “I will announce it later”
中 “Strict management after approval”… It seems to be in a hurry, conscious of a competitive vaccine
China, virtually starting vaccination… 10 provinces including Guangdong and Jiangsu
[앵커]
The Chinese government is also the first to approve the domestic synofam corona 19 vaccine.
It was announced that the prevention rate was 79%, but it is expected that the full-scale vaccination will begin as the new year begins.
Correspondent Kang Seong-woong reports from Beijing.
[기자]
The Chinese government first approved the launch of a domestic vaccine on the last day of 2020.
Sinopharm, a state-owned pharmaceutical company, accepted the application based on the data collected during the phase 3 clinical trial.
Although development is not complete, authorities have acknowledged the need for emergency use as it is.
[천스페이 / 국가약품감독관리국 부국장 : 법률에 따라 시노팜사의 코로나19 백신 등록을 조건부로 승인했습니다.]
The prevention rate of conditionally licensed Chinese vaccines is around 79%.
It is lower than those made by US or German pharmaceutical companies, and slightly higher than those made by UK pharmaceutical companies.
Chinese pharmaceutical company Sinopharm, however, has postponed its disclosure, saying it will release specific data later.
[우융린 / 중국 제약사 시노팜 사장 : 상세한 데이터는 조금 지나서 공개할 수 있을 것입니다. 국내외 과학 저널에도 발표할 것입니다.]
China, suffering from COVID-19 responsibility, has hurried to develop vaccines as a public good.
In addition, as Western countries competitively released vaccines, it would have been difficult to delay further release.
The Chinese government has stated that it will perform thorough quality control in the future as it has conditionally allowed it.
[정종웨이 / 국무원 연합방역기구 백신개발팀장 : 안전성이 제일 중요합니다. 이것이 우리가 백신을 개발하는 과정에서 준수하는 기본 원칙입니다.]
China has already begun vaccination in 10 provinces including Guangdong, Jiangsu and Sichuan.
We have even completed transport training with the goal of inoculating 50 million people with a high risk of infection by New Year’s Day next year.
It was heralded that the vaccinations in China will be in full swing from the beginning of the new year.
Overseas, countries with large populations in South America and Asia, such as Brazil and Indonesia, mainly contracted vaccines made in China.
As the dose increases, the superiority and inferiority to other vaccines are expected to gradually become masked.
YTN Sungwoong Kang from Beijing[[email protected]]is.
[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]